Publications by authors named "Fotini Iatridi"

Chronic kidney disease (CKD) has emerged as a critical global public health concern. This condition is strongly associated with an increased risk of atherosclerotic cardiovascular disease and acute coronary syndromes (ACS) which have been recently renamed as acute myocardial ischemic syndromes (AMIS). In CKD patients, the atypical presentation of symptoms complicates the diagnosis and management of angina, a condition that can, if not promptly addressed, rapidly progress to myocardial infarction.

View Article and Find Full Text PDF

Introduction Vascular dysfunction is a hallmark of chronic kidney disease (CKD), with previous studies showing progressively deteriorating microvascular reactivity in skeletal muscles with advancing CKD stages. Additionally, cognitive impairment is quite common in CKD patients, as significant determinants of brain activation, i.e.

View Article and Find Full Text PDF

Introduction: Kidney transplant recipients (KTRs) have substantially lower risk for cardiovascular events compared to dialysis, but it remains significantly higher than in the general population due to the synergistic action of traditional and nontraditional factors. Among them, endothelial dysfunction is suggested to be involved pathogenetically in cardiovascular and renal disease progression, with its improvement being another potential benefit of transplantation.

Areas Covered: VOP was the first technique to be used, followed by several functional methods, most commonly FMD.

View Article and Find Full Text PDF

Objectives: Endothelial dysfunction is associated with increased cardiovascular risk in individuals with autoimmune diseases. This systematic review and meta-analysis included studies assessing endothelial function with functional methods in children with rheumatic diseases versus controls.

Methods: Literature search involved PubMed and Scopus databases (from inception to February 2024) and manual reference screening.

View Article and Find Full Text PDF

Introduction Cardiac arrhythmias are the leading mortal cause of end-stage kidney disease (ESKD), and autonomic dysfunction plays a predominant role. This is the first study to compare baroreflex sensitivity (BRS) and hemodynamic responses at rest and after mental and physical stimulation maneuvers between hemodialysis (HD) and peritoneal dialysis (PD) patients. Methods A total of 68 ESKD patients (34 HD and 34 PD, matched for age, sex, and dialysis vintage) were included.

View Article and Find Full Text PDF

Background: Pulmonary circulation is particularly overloaded in hemodialysis patients with high interdialytic weight gain (IDWG), as evidenced by deterioration in right ventricular function indices. This study aimed to evaluate the impact of the degree of fluid accumulation on left ventricular (LV) systolic and diastolic function and sizing characteristics.

Methods: This is a post hoc analysis of a cross-over study in 41 hemodialysis patients.

View Article and Find Full Text PDF

Purpose Of Review: Chronic kidney disease (CKD) is associated with elevated cardiovascular risk and progression to kidney failure, despite advances in therapy with renin-angiotensin system inhibitors and sodium-glucose-co-transporter-2 inhibitors. Overactivation of the aldosterone pathway contributes to residual cardiorenal risk. Nonsteroidal mineralocorticoid receptor antagonists (MRAs) have shown efficacy in reducing cardiorenal outcomes in patients with albuminuric diabetic kidney disease, providing a rationale to explore broader aldosterone pathway inhibition in CKD.

View Article and Find Full Text PDF

Introduction: Diabetic kidney disease (DKD) is a leading cause of chronic kidney disease worldwide. Endothelin-1 (ET-1) is a potent vasoconstrictor secreted by vascular endothelial cells, actively involved in the pathophysiology of numerous cardiovascular diseases. Based on the differential downstream effects of ET-1 binding to its two distinct types of receptors (ET/ET) within the kidney, selective ET receptor blockade has been long proposed as a promising treatment modality for DKD.

View Article and Find Full Text PDF

We read with interest the study by Han et al., offering important insights into the associations between different levels of physical and muscle-strengthening activities and chronic kidney disease (CKD) prevalence in hypertensive patients in Korea. However, when reading the paper, we noticed some issues that warrant discussion.

View Article and Find Full Text PDF

Introduction: Sex differences have a significant role on epidemiology of cardiovascular complications in chronic kidney disease. Among hemodialysis patients, central blood pressure (BP) levels and increased arterial stiffness parameters are independent predictors of cardiovascular and all-cause- mortality.

Aim: To examine the potential differences in ambulatory central BP and arterial stiffness parameters between male and female hemodialysis patients.

View Article and Find Full Text PDF

Uromodulin is a kidney-specific glycoprotein which is uniquely synthesized by the epithelial cells lining the thick ascending limb and early distal convoluted tubule. Among multiple roles in complex physiological and pathological processes, uromodulin mediates renal sodium handling through modulating tubular sodium transporters that reabsorb sodium and therefore is putatively linked to hypertension through generating sodium sensitivity of blood pressure. This review aims to present an updated overview of the role of uromodulin in sodium renal handling and summarize the existing evidence originating from preclinical, genetic, and clinical studies that support a relationship between uromodulin and sodium-sensitive hypertension.

View Article and Find Full Text PDF

Background: Nocturnal hypertension is associated with an increased risk for renal and cardiovascular events in patients with chronic kidney disease (CKD). Endothelial dysfunction and microvascular damage are highly prevalent in CKD and related to CKD progression and adverse cardiovascular outcomes. The aim of this analysis was to compare for the first time microcirculatory function parameters and central hemodynamics in CKD patients with and without nocturnal hypertension.

View Article and Find Full Text PDF

Nocturnal hypertension is highly prevalent in patients with chronic kidney disease (CKD) and represents a strong predictor of cardiovascular events. Increased blood pressure variability (BPV) is also independently associated with cardiovascular events in these patients. Differences in short-term BPV indices between CKD patients with and without nocturnal hypertension have not been previously studied.

View Article and Find Full Text PDF

Introduction: Intradialytic hypertension (IDH) is associated with increased cardiovascular risk. Arterial stiffness is a strong predictor of adverse outcomes in dialysis patients and may contribute to the development of the phenomenon, as patients with IDH exhibit higher ambulatory aortic blood pressure (BP) and arterial stiffness parameters than patients without IDH.  Methods: This analysis examined the effect of low (137mEq/L) compared to standard (140mEq/L) dialysate sodium concentration on 48-hour aortic BP and arterial stiffness parameters in IDH patients.

View Article and Find Full Text PDF

Introduction Physical inactivity is common in chronic kidney disease (CKD) patients; several patient- and disease-related factors are linked to a sedentary lifestyle, but social and environmental influences remain unexplored. This study evaluates the level of physical activity in patients with CKD and investigates the associations with caregivers' physical activity levels, characteristics of the residential environment, and objective measures of exercise capacity. Methods Eighty CKD patients (20 per CKD stage 2-4) were included; patients and their carers filled out the International Physical Activity Questionnaire (IPAQ), questionnaires about residential environment and past exercise habits.

View Article and Find Full Text PDF

Aim: Controlled attenuation parameter (CAP) enables the noninvasive diagnosis of liver steatosis. Magnetic resonance imaging proton density fat fraction (MRI-PDFF) is increasingly used over biopsy for the assessment of steatosis in patients at risk for metabolic dysfunction-associated steatotic liver disease (MASLD). We assessed the accuracy of CAP for liver steatosis defined as MRI-PDFF ≥ 5%.

View Article and Find Full Text PDF

Purpose Of Review: To summarize the current evidence regarding epidemiology, clinical pathophysiology, and latest therapeutic approaches for the management of intradialytic hypertension (IDH).

Recent Findings: IDH is a rather common complication of dialysis, affecting 10-15% of the patient population and significantly increasing the cardiovascular risk. Its pathophysiology involves multiple mechanisms, including volume and sodium overload, sympathetic nervous system (SNS) and renin-angiotensin-aldosterone system (RAAS) overactivity, endothelial dysfunction, and arterial stiffness.

View Article and Find Full Text PDF

Purpose: Heart failure (HF) and atrial fibrillation (AF) are highly prevalent in hemodialysis. They are well-known significant modifiers of the disease associations with cardiovascular outcomes, but there is a lack of evidence regarding the effects of HF and AF on cardiorespiratory fitness. This study is the first to examine the possible association of the presence of HF and AF with exercise intolerance in patients undergoing hemodialysis.

View Article and Find Full Text PDF
Article Synopsis
  • Sodium-glucose co-transporter-2 inhibitors (SGLT2is) were found to significantly lower cardiovascular and all-cause mortality in people with chronic kidney disease (CKD) based on a systematic review of 11 studies involving over 83,000 participants.
  • These medications reduced the risk of cardiovascular death by 14%, all-cause death by 15%, and major adverse cardiac events (MACE) by 13%, showing consistent effects across different levels of kidney function and risk categories.
  • The findings suggest that SGLT2is could be beneficial for CKD patients, regardless of their baseline kidney function or cardiovascular risk level, highlighting their potential in improving health outcomes in this population.
View Article and Find Full Text PDF
Article Synopsis
  • The KDIGO 2024 Guidelines for chronic kidney disease (CKD) are a significant update, occurring 12 years after the influential 2012 guidelines.
  • These new guidelines emphasize the integration of recent therapies that have shown success in treating CKD and related cardiovascular issues, making them relevant for both children and adults.
  • The commentary highlights that despite advancements, the diagnosis and treatment of CKD remain subpar across Europe, suggesting that these guidelines serve as a crucial call to action for improving care in this area.
View Article and Find Full Text PDF